HI-TECH PHARMACAL INC
HITK
HITK was delisted on the 16th of April, 2014.
105 hedge funds and large institutions have $414M invested in HI-TECH PHARMACAL INC in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 21 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 28
26% more capital invested
Capital invested by funds: $329M → $414M (+$85.1M)
19% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 21
4% more funds holding
Funds holding: 101 → 105 (+4)
4% more call options, than puts
Call options by funds: $660K | Put options by funds: $634K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$38.5M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.6M |
| 3 |
Morgan Stanley
New York
|
+$13M |
| 4 |
Millennium Management
New York
|
+$11.6M |
| 5 |
JP Morgan Chase
New York
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$64.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.8M |
| 3 |
O
OrbiMed
New York
|
-$12.3M |
| 4 |
BC
Broadfin Capital
New York
|
-$9.07M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.24M |
HITK Hedge Fund Activity: Q3 2013 in Review
105 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in HI-TECH PHARMACAL INC (HITK) for Q3 2013, worth a combined $414M — up 26% from $329M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HITK positions and 21 closed out — a net gain of 4 holders — while 39 added to existing stakes and 28 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $38.5M. The largest seller was Royce & Associates, cutting an estimated $64.5M.
- 105 institutional investors held HI-TECH PHARMACAL INC (HITK) as of Q3 2013, up from 101 in Q2 2013.
- Funds reported $414M of HI-TECH PHARMACAL INC stock for Q3 2013, up 26% quarter-over-quarter.
- 25 funds opened new HI-TECH PHARMACAL INC positions in Q3 2013 and 21 closed out, a net change of +4 holders.
- The largest HI-TECH PHARMACAL INC buyer in Q3 2013 was AQR Capital Management, an estimated $38.5M added.
- The largest HI-TECH PHARMACAL INC seller in Q3 2013 was Royce & Associates, an estimated $64.5M sold.
Based on aggregated 13F filings for Q3 2013.